Swiss Regulatory Aspects & Evaluation for mRNABased Vaccines & Therapeutic Pathways to Approval
Time: 12:15 pm
day: Day 1 Track 2 AM
Details:
- Exploring harmonisation regulatory challenges and expectations for new mRNA drugs applications and documentation
- Delineating the mRNA platform definition for vaccine, therapeutic and broader applications
- Highlighting regulatory progress in personalised mRNA cancer vaccines and manufacturing considerations
